St. Louis, MO, United States of America

Alison M Goate

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Richmond Heights, MO (US) (1999 - 2000)
  • St. Louis, MO (US) (2001 - 2020)

Company Filing History:


Years Active: 1999-2020

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Alison M Goate: Innovator in Neurodegenerative Research**

Introduction

Alison M Goate is a distinguished inventor based in St. Louis, MO, with a significant contribution to the field of neurodegenerative diseases. She holds a total of eight patents that reflect her innovative approach to research, particularly related to proteinopathies. Her work is pioneering in identifying subjects at risk for various conditions, enhancing our understanding of complex neurological disorders.

Latest Patents

Alison's latest patent, titled "Sequences associated with TDP-43 proteinopathies and methods of using the same," presents crucial nucleic acids and peptides. This invention focuses on methods that utilize these nucleic acids and peptides to identify individuals at risk for TDP-43 proteinopathy. The technology also encompasses an array comprising these nucleic acids and peptides, underscoring its potential in diagnostic applications.

Career Highlights

Throughout her career, Alison M Goate has been affiliated with notable institutions such as Washington University and the University of South Florida. Her work has not only contributed to the academic community but has also laid a foundation for future research in understanding neurodegenerative diseases and their impact on human health.

Collaborations

Alison has collaborated with esteemed colleagues including Nigel J Cairns and Robert H Baloh. These partnerships have further enhanced her research capabilities and allowed for a multidisciplinary approach to tackling the challenges posed by neurodegenerative diseases.

Conclusion

Alison M Goate's contributions to the field of neurodegenerative research through her inventions and collaborations remain vital in advancing our understanding and diagnosis of proteinopathies. Her innovative spirit and commitment to research continue to inspire future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…